Acelot Inc Profile last edited on: 1/10/17
CAGE: 4J8Q7
UEI: CC15RKJHFRE1
Business Identifier: drug discovery algorithm finding effective disease-modifying therapies with minimal side-effects for central nervous system diseases such as Alzheimer's and Parkinson's Disease. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
5385 Hollister Avenue Suite 111
Santa Barbara, CA 93111
Santa Barbara, CA 93111
| (805) 617-3610 |
| singhambujk@gmail.com |
| www.acelot.com |
Location: Single
Congr. District: 24
County: Santa Barbara
Congr. District: 24
County: Santa Barbara
Public Profile
Acelot Inc is a drug development company applying patented searching and mining algorithms to complex biological and chemical data to discover new leads for central nervous system diseases, including Alzheimer's and Parkinson's, and various types of cancer. The firmâs ability to analyze large biological pathways opens up new and previously unknown options for drug targets. Acelot's unique graph-based in-silico algorithm approach results in small molecule leads that are tailored to biological targets and screen against undesired targets, minimizing the risk of side-effects.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2016 | 1 | NIH | $223,325 | |
| Project Title: Discovery of Lxr Agonists Via Pharmacophore Space Mining | ||||
| 2014 | 1 | NSF | $150,000 | |
| Project Title: A Learning Drug Discovery Platform in the Cloud | ||||
| 2012 | 1 | NIH | $183,000 | |
| Project Title: Discovery Of A-Beta Oligomer Antagonists Via 3d Pharmacophore Space Analysis | ||||
| 2011 | 1 | NSF | $150,000 | |
| Project Title: Identifying Drug Leads via 3D Pharmacophore Space Analysis | ||||
| 2010 | 2 | NIH | $1,346,534 | |
| Project Title: Scalable tools for the analysis of chemical compounds using graph-based querying | ||||
Key People / Management
Ambuj Kumar Singh -- President; Chief Executive Officer
Stuart C Feinstein -- Scientific Advisor
Christian Lang -- Chief Technology Officer
William Maxwell Lindstrom
Prakash Natarajan -- Applications Developer
Gilbert M Rishton -- Scientific Advisor
Stuart C Feinstein -- Scientific Advisor
Christian Lang -- Chief Technology Officer
William Maxwell Lindstrom
Prakash Natarajan -- Applications Developer
Gilbert M Rishton -- Scientific Advisor
Company News
There are no news available.
